BRIDGEWATER, NJ--(Marketwire - February 28, 2008) - Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced that a New Drug Application (NDA) has been submitted for EMBEDA™, a pharmacological abuse-deterrent, extended-release morphine product candidate.
